SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021235
Filing Date
2017-11-02
Accepted
2017-11-02 16:31:42
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20170930.htm 10-Q 1189343
2 EX-10.1 snss-ex101_320.htm EX-10.1 62317
3 EX-31.1 snss-ex311_11.htm EX-31.1 16366
4 EX-31.2 snss-ex312_13.htm EX-31.2 16316
5 EX-32.1 snss-ex321_12.htm EX-32.1 6424
6 GRAPHIC g2017110217044344616192.jpg GRAPHIC 3336
  Complete submission text file 0001564590-17-021235.txt   4213106

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snss-20170930.xml EX-101.INS 786574
8 XBRL TAXONOMY EXTENSION SCHEMA snss-20170930.xsd EX-101.SCH 40359
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20170930_cal.xml EX-101.CAL 38364
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20170930_def.xml EX-101.DEF 120187
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20170930_lab.xml EX-101.LAB 292028
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20170930_pre.xml EX-101.PRE 200236
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 171172860
SIC: 2834 Pharmaceutical Preparations